3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
2
Triple Negative Breast Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Melanoma
1
Hemangiosarcoma
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Interventions
Temozolomide
42
Magnetic Resonance Spectroscopy
41
Radiotherapy
22
Specimen Handling
18
Biopsy
13
X-Rays
10
Radiation
10
trametinib
8
Bevacizumab
8
Nivolumab
7
Blood Specimen Collection
7
olaparib
6
fluorodopa F 18
6
dabrafenib
6
Radiotherapy, Intensity-Modulated
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
Lomustine
6
pembrolizumab
5
abemaciclib
5
Standard of Care
5
vorasidenib
4
ulixertinib
4
larotrectinib
4
ivosidenib
4
erdafitinib
4
Surgical Procedures, Operative
4
Dianhydrogalactitol
4
Cyclophosphamide
4
Aminolevulinic Acid
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
MK 2206
×
1 year
×
Clear all
No trials found.